Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.

Inhibitory role of prohibitin in human ovarian epithelial cancer.

Jia L, Ren JM, Wang YY, Zheng Y, Zhang H, Zhang Q, Kong BH, Zheng WX.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2247-55. eCollection 2014.

2.

Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors.

McCluggage WG, Strand K, Abdulkadir A.

Int J Gynecol Cancer. 2002 Jan-Feb;12(1):62-5.

PMID:
11860537
3.

Tubal origin of 'ovarian' low-grade serous carcinoma.

Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W.

Mod Pathol. 2011 Nov;24(11):1488-99. doi: 10.1038/modpathol.2011.106. Epub 2011 Jun 24.

4.

[Expression and promotor methylation of p73 gene in ovarian epithelial tumors].

Zhang YL, Guo XR, Shen DH, Cheng YX, Liang XD, Chen YX, Wang Y.

Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):33-8. Chinese.

PMID:
22455848
5.

Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.

Zagorianakou N, Stefanou D, Makrydimas G, Zagorianakou P, Briasoulis E, Karavasilis V, Pavlidis N, Agnantis NJ.

Histol Histopathol. 2006 Apr;21(4):341-7.

PMID:
16437378
6.

Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.

Ye F, Li Y, Hu Y, Zhou C, Hu Y, Chen H.

Int J Gynecol Cancer. 2010 Aug;20(6):958-64. doi: 10.1111/IGC.0b013e3181e6fee1.

PMID:
20683402
7.

Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.

Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA.

J Pathol. 2003 Oct;201(2):229-37.

PMID:
14517840
8.

Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.

Ahmed N, Riley C, Rice GE, Quinn MA, Baker MS.

J Histochem Cytochem. 2002 Oct;50(10):1371-80.

PMID:
12364570
9.

[Expression of folate receptor alpha in ovarian epithelial tumors].

Shen DH, Xie JL, Zhang YL, Wang Y.

Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):747-51. Chinese.

PMID:
21215165
10.

HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.

Ota T, Gilks CB, Longacre T, Leung PC, Auersperg N.

Reprod Sci. 2007 Sep;14(6):605-14.

PMID:
17959889
11.

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH.

Clin Cancer Res. 2005 Sep 1;11(17):6116-26.

12.

Apoptotic and proliferative activity in ovarian benign, borderline and malignant tumors.

Liu A, Chen L, Ngan HY, Khoo US, Zhao Y, Cheung AN.

Chin Med Sci J. 2002 Jun;17(2):106-11.

PMID:
12906164
13.

Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.

Ye F, Hu Y, Zhou C, Hu Y, Chen H.

Pathobiology. 2012;79(6):307-13. doi: 10.1159/000338078. Epub 2012 Jun 9.

PMID:
22688257
14.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
15.

Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.

Brun JL, Cortez A, Commo F, Uzan S, Rouzier R, Daraï E.

Int J Oncol. 2008 Dec;33(6):1239-46.

PMID:
19020757
16.

Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma.

Khin EE, Kikkawa F, Ino K, Suzuki T, Shibata K, Kajiyama H, Tamakoshi K, Mizutani S.

Int J Gynecol Pathol. 2003 Apr;22(2):175-80.

PMID:
12649673
17.

Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.

Lu JJ, Zheng Y, Kang X, Yuan JM, Lauchlan SC, Pike MC, Zheng W.

Gynecol Oncol. 2000 Nov;79(2):158-68.

PMID:
11063638
18.

Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.

Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC.

Gynecol Oncol. 1998 Apr;69(1):23-31.

PMID:
9570994
19.

Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.

Zhao C, Bratthauer GL, Barner R, Vang R.

Am J Surg Pathol. 2007 Sep;31(9):1378-86.

PMID:
17721194
20.

Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis.

Jia L, Yi XF, Zhang ZB, Zhuang ZP, Li J, Chambers SK, Kong BH, Zheng W.

Neoplasma. 2011;58(2):104-9.

PMID:
21275458
Items per page

Supplemental Content

Write to the Help Desk